Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoyang Liu

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2025
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and AdolescentsHaoyang Liu, Haolin Liu, Junru Chen, et al.
Molecular Cancer|June 26, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinomaJunjie Zhao, Yanfeng Tang, Xu Hu, et al.
Nature|May 22, 2025
Signatures of chiral superconductivity in rhombohedral grapheneTonghang Han, Zhengguang Lu, Zach Hadjri, et al.
Journal for Immunotherapy of Cancer|May 28, 2026
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallengeYanfeng Tang, Junru Chen, Jue Hu, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2023
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancerNanwei Xu, Jinge Zhao, Fengnian Zhao, et al.
Cancer Research|October 17, 2023
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the ProstateJinge Zhao, Nanwei Xu, Sha Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2024
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell CarcinomaJunru Chen, Xu Hu, Junjie Zhao, et al.
Medical Physics|December 13, 2025
Multiinstitutional survey of source modeling parameters for proton pencil beam scanning treatment planning system commissioningSerdar Charyyev, Vivek Maradia, Chih-Wei Chang, et al.
Nature Communications|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targetsXingming Zhang, Junjie Zhao, Xiaoxue Yin, et al.
JAMA Oncology|August 14, 2025
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical TrialXingming Zhang, Haoyang Liu, Jiayu Liang, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2025
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and AdolescentsHaoyang Liu, Haolin Liu, Junru Chen, et al.
Molecular Cancer|June 26, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinomaJunjie Zhao, Yanfeng Tang, Xu Hu, et al.
Nature|May 22, 2025
Signatures of chiral superconductivity in rhombohedral grapheneTonghang Han, Zhengguang Lu, Zach Hadjri, et al.
Journal for Immunotherapy of Cancer|May 28, 2026
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallengeYanfeng Tang, Junru Chen, Jue Hu, et al.
Journal of Cancer Research and Clinical Oncology|March 13, 2023
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancerNanwei Xu, Jinge Zhao, Fengnian Zhao, et al.
Cancer Research|October 17, 2023
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the ProstateJinge Zhao, Nanwei Xu, Sha Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2024
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell CarcinomaJunru Chen, Xu Hu, Junjie Zhao, et al.
Medical Physics|December 13, 2025
Multiinstitutional survey of source modeling parameters for proton pencil beam scanning treatment planning system commissioningSerdar Charyyev, Vivek Maradia, Chih-Wei Chang, et al.
Nature Communications|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targetsXingming Zhang, Junjie Zhao, Xiaoxue Yin, et al.
JAMA Oncology|August 14, 2025
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical TrialXingming Zhang, Haoyang Liu, Jiayu Liang, et al.
Pageof 14